Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 30th, there was short interest totalling 10,300 shares, an increase of 1,371.4% from the December 15th total of 700 shares. Approximately 0.1% of the company's shares are short sold. Based on an average daily trading volume, of 54,500 shares, the short-interest ratio is currently 0.2 days.
Arbor Rapha Capital Bioholdings Corp. I Price Performance
Shares of ARCK stock opened at $11.90 on Wednesday. Arbor Rapha Capital Bioholdings Corp. I has a one year low of $9.93 and a one year high of $15.59. The company has a 50 day moving average price of $10.93 and a 200 day moving average price of $10.41.
Get
Arbor Rapha Capital Bioholdings Corp. I alerts:
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the company. Elequin Capital LP acquired a new stake in shares of Arbor Rapha Capital Bioholdings Corp. I in the 3rd quarter worth about $25,000. Mint Tower Capital Management B.V. bought a new position in shares of Arbor Rapha Capital Bioholdings Corp. I during the 3rd quarter valued at about $818,000. Parallax Volatility Advisers L.P. acquired a new position in shares of Arbor Rapha Capital Bioholdings Corp. I in the third quarter worth about $877,000. Balyasny Asset Management LLC boosted its holdings in shares of Arbor Rapha Capital Bioholdings Corp. I by 12.5% in the third quarter. Balyasny Asset Management LLC now owns 225,005 shares of the company's stock worth $2,277,000 after buying an additional 25,005 shares during the period. Finally, Saba Capital Management L.P. boosted its holdings in shares of Arbor Rapha Capital Bioholdings Corp. I by 18.1% in the third quarter. Saba Capital Management L.P. now owns 1,631,601 shares of the company's stock worth $16,512,000 after buying an additional 250,000 shares during the period. 68.70% of the stock is currently owned by hedge funds and other institutional investors.
About Arbor Rapha Capital Bioholdings Corp. I
(Get Rating)
Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector.
See Also
- Get a free copy of the StockNews.com research report on Arbor Rapha Capital Bioholdings Corp. I (ARCK)
- Insulet Has Potential To Gain More Than Analysts Are Forecasting
- Cathie Wood Is Buying These Stocks, Should You?
- Thor Industries Hammered Its Numbers. Is it a Buy?
- Tritium Is the Largest DC EV Charger Maker You've Never Heard Of
- United Airlines Soars Ahead of Earnings...Time to Deplane?
Receive News & Ratings for Arbor Rapha Capital Bioholdings Corp. I Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbor Rapha Capital Bioholdings Corp. I and related companies with MarketBeat.com's FREE daily email newsletter.
Arbor Rapha Capital BioHoldings Corp.I(納斯達克:ARCK-GET評級)是12月份空頭股數大幅上漲的目標。截至12月30日,空頭股數共有10300股,比12月15日的700股增加了1371.4%。該公司約0.1%的股票被賣空。以日均成交量五萬四千五百股計算,目前短息比率為零點二天。
Arbor Rapha Capital BioHoldings Corp.I價格表現
Arck的股票週三開盤報11.90美元。Arbor Rapha Capital BioHoldings Corp.I的一年低點為9.93美元,一年高位為15.59美元。該公司的50日移動均線價格為10.93美元,200日移動均線價格為10.41美元。
到達
Arbor Rapha Capital BioHolding Corp.警報:
機構資金流入和流出
幾家機構投資者和對沖基金最近對他們在該公司的頭寸進行了調整。Elequin Capital LP在第三季度收購了Arbor Rapha Capital BioHoldings Corp.I價值約25,000美元的新股。鑄幣塔資本管理公司(Mint Tower Capital Management B.V.)在第三季度購買了Arbor Rapha Capital BioHoldings Corp.I的新頭寸,價值約818,000美元。Parallax Volatility Advisers L.P.在第三季度收購了Arbor Rapha Capital BioHoldings Corp.I價值約87.7萬美元的新股票頭寸。Balyasny Asset Management LLC在第三季度增持了Arbor Rapha Capital BioHoldings Corp.I的股票12.5%。Balyasny Asset Management LLC現在擁有225,005股該公司的股票,價值2,277,000美元,在此期間又購買了25,005股。最後,Saba Capital Management L.P.在第三季度將其持有的Arbor Rapha Capital BioHoldings Corp.I的股票增加了18.1%。Saba Capital Management L.P.在此期間又購買了250,000股,現在擁有1,631,601股該公司股票,價值16,512,000美元。68.70%的股票目前由對沖基金和其他機構投資者持有。
關於Arbor Rapha Capital BioHoldings Corp.
(獲取評級)
Arbor Rapha Capital BioHoldings Corp.I沒有重大業務。公司專注於與一家或多家企業進行合併、資本換股、資產收購、股票購買、重組或類似的業務合併。它打算確定生物製藥行業的收購機會。
另請參閱
- 免費獲取StockNews.com關於Arbor Rapha Capital BioHoldings Corp.I(Arck)的研究報告
- Insulet有潛力獲得超過分析師預測的收益
- 凱西·伍德正在購買這些股票,你應該這樣做嗎?
- 雷神工業重創了它的業績。這是買來的嗎?
- 氚是你從未聽說過的最大的DC電動汽車充電器製造商
- 美國聯合航空公司盈利前飆升...是時候下機了?
獲得Arbor Rapha Capital BioHoldings Corp.I Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Arbor Rapha Capital BioHoldings Corp.I和相關公司的最新新聞和分析師評級的每日簡要摘要。